Ibrahim Ramy Riad Ahmed 4

What Happened Ibrahim Ramy Riad Ahmed, President of the PDT BU at Takeda Pharmaceutical Co. (TAK), received an award of 25,078 restricted stock units (RSUs) on July 1, 2026. The grant is reported as an acquisition (code A) at $0.00 per share — these are compensation RSUs, not an open‑market purchase or sale. Each RSU represents a contingent right to one American Depositary Share (ADS).

Key Details

• Transaction date: July 1, 2026; Form filed July 6, 2026 (Accession 0001395064-26-000256). The filing does not indicate a late-report code.
• Award: 25,078 RSUs reported as acquired at $0.00 (compensation grant).
• Vesting: RSUs vest in three equal annual installments beginning July 1, 2027 (per footnote).
• Shares owned after transaction: Not disclosed in this filing.
• Footnote: F1 — each RSU equals one ADS; vesting schedule noted above.

Context This is a compensation grant (RSUs), which is common for executives and is not an immediate cash purchase or sale. The economic value will depend on Takeda’s ADS price when each tranche vests and is settled. Such awards are typically part of incentive/retention pay and do not by themselves indicate buying or selling sentiment.